e-learning
resources
Munich 2006
Monday 04.09.2006
Epidemiology of susceptible, resistant and multidrug-resistant tuberculosis (MDR-TB)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long-term results of drug resistant tuberculosis treatment
J. Beli, J. Bushati (Tirana, Albania)
Source:
Annual Congress 2006 - Epidemiology of susceptible, resistant and multidrug-resistant tuberculosis (MDR-TB)
Session:
Epidemiology of susceptible, resistant and multidrug-resistant tuberculosis (MDR-TB)
Session type:
Poster Discussion
Number:
2249
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Beli, J. Bushati (Tirana, Albania). Long-term results of drug resistant tuberculosis treatment. Eur Respir J 2006; 28: Suppl. 50, 2249
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Long-term results of treatment with bedaquiline in patients with drug-resistant tuberculosis
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Long-term results of multidrug-resistant tuberculosis treatment.
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
The efficacy of treatment of patients with drug resistant tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 661s
Year: 2007
Treatment results in patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis
Source: Eur Respir J , 49 (3) 1601799; DOI: 10.1183/13993003.01799-2016
Year: 2017
Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosis
Source: Eur Respir J, 50 (5) 1701552; 10.1183/13993003.01552-2017
Year: 2017
Predicting outcomes and drug resistance with standardised treatment of active tuberculosis
Source: Eur Respir J 2010; 36: 870-877
Year: 2010
Evaluation of characteristics and treatment results of patients treated as multidrug resistant tuberculosis
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
Long term treatment outcome in multi drug resistant tuberculosis
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
Treatment of resistant tuberculosis in patients having isolates resistant to multiple antituberculosis drugs
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Treatment results of multidrug resistant tuberculosis and the factors affecting treatment results
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008
The efficiency of including the II-line drugs to the treatment regimen of isoniazid-resistant tuberculosis.
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Isoniazid resistance is associated with delayed culture conversion during anti-tuberculosis treatment among patients with pulmonary tuberculosis
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis
Source: Eur Respir J , 49 (4) 1700317; DOI: 10.1183/13993003.00317-2017
Year: 2017
Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis
Source: Eur Respir J , 49 (4) 1700173; DOI: 10.1183/13993003.00173-2017
Year: 2017
A study on the clinical efficacy of a combination regimen with azithromycin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 722s
Year: 2004
Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Treatment outcome of multi-drug resistant tuberculosis
Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis
Year: 2004
The adverse effects of multidrug resistant tuberculosis treatment and relationship with treatment results
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept